How Bristol-Myers fumbled defense of $4 billion drug

Article Abstract:

Chief Executive Peter R. Dolan, Bristol-Myers Squibb Co. of the United States has had his offices raided by the United States Federal Bureau of Investigation. There have been concerns about how management tried to protect its best selling drug Plavix from generic competition. Share price is down by 60 percent since Mr. Dolan became Chief Executive Officer.

United States, Patents & copyrights, Evaluation, Intellectual property, Bristol-Myers Squibb Co., BMY, Company overview, Dolan, Peter R.

---

Pfizer's strategy takes shape; Europe sales team may be cut deeply; reorganizing R&D

Article Abstract:

Jeffrey B. Kindler, new CEO of Pfizer Inc., is preparing to announce his plans for the company, which are expected to include major restructuring and significant job cuts. Mr. Kindler, who has already made a number of changes in the six months since he became CEO, plans to cut expenses while keeping research-and-development costs stable.

Europe, Strategy & planning, Organizational history, Executive changes & profiles, Personnel administration, Planning, Officials and employees, Human resource management, Pfizer Inc., Company restructuring/company reorganization, Reorganization and restructuring, Company personnel management, PFE, Company business planning, Company organization, Kindler, Jeffrey B.

---

Lilly sets deal to acquire Icos for about $2.1 billion

Article Abstract:

Eli Lilly & Co. of the United States is to purchase ICOS Corp. also of the United States for $2.1 billion. The move would give Eli Lilly & Co. full patent ownership of the erectile-dysfunction medication Cialis. Cialis has a 25 percent market share with international sales of $456 million in the first half of 2006.

Acquisitions & mergers, Drugs, Biotechnology industry, Mergers, acquisitions and divestments, Biotechnology industries, Company acquisition/merger, Eli Lilly and Co., LLY, ICOS Corp., ICOS

Similar abstracts:

• Abstracts: ECB tops off a day of rate increases. Europe's rates are likely to keep rising
• Abstracts: Siemens plans acquisition to boost internet strategy. Too many chiefs at Siemens
• Abstracts: Unilever finds a buyer for some Europe assets. Eurazeo sets deal to buy Apcoa. EMI nears deal to be purchased by private-equity group Permira
• Abstracts: Riga processor modernizes factory. Esbjerg's first seiner in 20 years. Established Latvian builder ready to: step up hull production
• Abstracts: Larissa builds up her factory fleet. Norwegian skipper Gunnar Stokke says that it's: savings all round with Russian-built ship!

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.